Justin Chakma

SPRY

Justin Chakma serves as Chief Business Officer at ARS Pharmaceuticals, Inc. (SPRY). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

6 trades

$8.56M

Net Position

Net Seller

$8.56M

Companies Traded

SPRY

Active Period

Nov 2024 – Nov 2025

6 total trades

Most Recent

Sell SPRY

Nov 12, 2025 · $1.48M

Justin Chakma's Insider Trading at ARS Pharmaceuticals, Inc. (SPRY)

Buys

0 · $0.00

Sells

6 · $8.56M

Total Shares Bought

Total Shares Sold

695,625

SPRY Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 12, 2025	Sell	166,380	$8.87	$1.48M	0
Dec 13, 2024	Sell	144,605	$12.23	$1.77M	136,380
Dec 12, 2024	Sell	50,000	$13.15	$657.6K	136,380
Dec 6, 2024	Sell	144,640	$14.11	$2.04M	136,380
Dec 4, 2024	Sell	90,000	$13.43	$1.21M	136,380
Nov 27, 2024	Sell	100,000	$14.12	$1.41M	203,566